Stay updated on Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial
Sign up to get notified when there's something new on the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page.

Latest updates to the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page has been updated to reflect a new version number, v2.15.2, and the previous version, v2.15.0, has been removed. Additionally, a specific citation related to insulin use and glycemic control has been added, while the erratum for that citation has been deleted.SummaryDifference0.2%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to reflect a new version of the study, with a focus on the Glooko mobile insulin dosing system for insulin degludec titration in patients with Type 2 Diabetes Mellitus. Key details about the study's design and inclusion criteria have been revised, indicating a shift in the study's focus and methodology.SummaryDifference25%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1.0%
Stay in the know with updates to Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page.